1. Home
  2. ENGN vs TRAK Comparison

ENGN vs TRAK Comparison

Compare ENGN & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

SELL

Current Price

$1.95

Market Cap

117.2M

Sector

N/A

ML Signal

SELL

TRAK

ReposiTrak Inc.

SELL

Current Price

$7.25

Market Cap

125.2M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
ENGN
TRAK
Founded
1999
1990
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
117.2M
125.2M
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
ENGN
TRAK
Price
$1.95
$7.25
Analyst Decision
Buy
Analyst Count
9
0
Target Price
★ $4.29
N/A
AVG Volume (30 Days)
★ 1.5M
79.1K
Earning Date
12-21-2026
11-16-2026
Dividend Yield
N/A
★ 1.09%
EPS Growth
★ 56.85
11.43
EPS
N/A
★ 0.39
Revenue
N/A
★ $21,007,076.00
Revenue This Year
N/A
$9.50
Revenue Next Year
N/A
$10.00
P/E Ratio
★ N/A
$18.93
Revenue Growth
N/A
★ 4.84
52 Week Low
$1.40
$6.61
52 Week High
$12.25
$14.55

Technical Indicators

Market Signals
Indicator
ENGN
TRAK
Relative Strength Index (RSI) 55.31 48.00
Support Level $1.61 $6.89
Resistance Level $8.93 $7.46
Average True Range (ATR) 0.18 0.37
MACD 0.07 0.06
Stochastic Oscillator 47.17 57.35

Price Performance

Historical Comparison
ENGN
TRAK

About ENGN enGene Holdings Inc.

enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. It is developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform.

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

Share on Social Networks: